Coronavirus Live Count Map India
remove_red_eye 625 Views
COVID-19 Vaccine Updates
#Business And Medicine #Emergency Medicine #Hospital Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health #Pulmonary Medicine
Regeneron Pharmaceuticals Inc has stated that its experimental two-antibody cocktail reduced viral levels and improved symptoms among non-hospitalized COVID-19 patients, thus improving its odds of becoming a treatment for COVID-19 disease.
Regeneron Chief Scientific Officer, George Yancopoulos, stated that they hope that these data will support an emergency use authorization (EUA) from the U.S. Food and Drug Administration. The treatment, called REGN-COV2, is also under investigation for use in hospitalized patients, and for prevention of infection in individuals who have been exposed to COVID-19. The treatment could help patients whose own immune system is not strong enough to fight the virus, mentioned Regeneron… (ET Healthworld – Reuters, September 30, 2020)